Trilogy Capital’s Vanguard Small-Cap ETF VB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,207
Closed -$290K 352
2024
Q4
$290K Buy
+1,207
New +$297K 0.01% 284
2024
Q2
Sell
-1,613
Closed -$369K 344
2024
Q1
$369K Buy
1,613
+228
+16% +$49K 0.02% 231
2023
Q4
$295K Sell
1,385
-60
-4% -$11.6K 0.02% 212
2023
Q3
$273K Sell
1,445
-29
-2% -$5.78K 0.02% 208
2023
Q2
$303K Sell
1,474
-1,902
-56% -$359K 0.02% 232
2023
Q1
$640K Sell
3,376
-313
-8% -$60.7K 0.05% 145
2022
Q4
$677K Buy
3,689
+1,113
+43% +$206K 0.05% 144
2022
Q3
$440K Buy
2,576
+223
+9% +$42.1K 0.04% 128
2022
Q2
$414K Sell
2,353
-645
-22% -$125K 0.04% 122
2022
Q1
$637K Sell
2,998
-180
-6% -$37.9K 0.05% 124
2021
Q4
$718K Sell
3,178
-37,163
-92% -$8.44M 0.05% 121
2021
Q3
$8.82M Buy
40,341
+392
+1% +$87.1K 0.67% 41
2021
Q2
$8.99M Buy
39,949
+37,614
+1,611% +$8.34M 0.66% 41
2021
Q1
$500K Buy
+2,335
New +$492K 0.04% 124
2018
Q4
Sell
-162
Closed -$26K 543
2018
Q3
$26K Hold
162
﹤0.01% 254
2018
Q2
$25K Sell
162
-133
-45% -$20.3K ﹤0.01% 238
2018
Q1
$43K Buy
+295
New +$44K 0.01% 173

Other funds holding VB

Trilogy Capital's VB Position: Q1 2025 in Review

Trilogy Capital sold out of Vanguard Small-Cap ETF (VB) in Q1 2025, closing a stake of 1,207 shares — an estimated $290K sold.

Trilogy Capital first reported a position in VB in Q1 2018 and held it in 17 quarters. The position peaked at $8.99M in Q2 2021. 2,157 funds tracked by Wall St. Rank hold VB as of Q1 2025.

  • Trilogy Capital reported no remaining Vanguard Small-Cap ETF position as of Q1 2025 after selling out during the quarter.
  • Trilogy Capital sold 1,207 Vanguard Small-Cap ETF shares in Q1 2025, an estimated $290K.
  • Trilogy Capital first reported a position in Vanguard Small-Cap ETF in Q1 2018 and held it in 17 quarters.
  • Trilogy Capital's Vanguard Small-Cap ETF position peaked at $8.99M in Q2 2021.
  • 2,157 funds tracked by Wall St. Rank held Vanguard Small-Cap ETF as of Q1 2025.

Based on Trilogy Capital's 13F filing for Q1 2025, filed 7 May 2025.